Centessa Pharmaceuticals Funding & Investors
Cambridge, MA
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
centessa.comTotal Amount Raised: $875,000,000
Centessa Pharmaceuticals Funding Rounds
Post Ipo Equity
$225,000,000
Post Ipo Equity
$100,000,000
Post Ipo Debt
$300,000,000
Post Ipo Debt Investors
Oberland CapitalSeries A
$250,000,000
Series A Investors
General AtlanticHenderson Global InvestorsVida VenturesEcoR1 CapitalLifeSci Venture PartnersSamsara BioCapitalT. Rowe PriceWellington ManagementBoxer CapitalCormorant Asset ManagementBiotechnology Value FundVenrock Healthcare Capital PartnersLogos CapitalFranklin Resources, Inc.IP GroupIPO
Unknown
Funding info provided by Diffbot.